| Literature DB >> 27918457 |
Li Wang1, Buqing Zhong2, Sotiris Vardoulakis3, Fengying Zhang4, Eva Pilot5, Yonghua Li6, Linsheng Yang7, Wuyi Wang8, Thomas Krafft9.
Abstract
Air pollution is an important public health problem in Europe and there is evidence that it exacerbates health inequities. This calls for effective strategies and targeted interventions. In this study, we conducted a systematic review to evaluate the effectiveness of strategies relating to air pollution control on public health and health equity in Europe. Three databases, Web of Science, PubMed, and Trials Register of Promoting Health Interventions (TRoPHI), were searched for scientific publications investigating the effectiveness of strategies on outdoor air pollution control, public health and health equity in Europe from 1995 to 2015. A total of 15 scientific papers were included in the review after screening 1626 articles. Four groups of strategy types, namely, general regulations on air quality control, road traffic related emission control interventions, energy generation related emission control interventions and greenhouse gas emission control interventions for climate change mitigation were identified. All of the strategies reviewed reported some improvement in air quality and subsequently in public health. The reduction of the air pollutant concentrations and the reported subsequent health benefits were more significant within the geographic areas affected by traffic related interventions. Among the various traffic related interventions, low emission zones appeared to be more effective in reducing ambient nitrogen dioxide (NO₂) and particulate matter levels. Only few studies considered implications for health equity, three out of 15, and no consistent results were found indicating that these strategies could reduce health inequity associated with air pollution. Particulate matter (particularly fine particulate matter) and NO₂ were the dominant outdoor air pollutants examined in the studies in Europe in recent years. Health benefits were gained either as a direct, intended objective or as a co-benefit from all of the strategies examined, but no consistent impact on health equity from the strategies was found. The strategy types aiming to control air pollution in Europe and the health impact assessment methodology were also discussed in this review.Entities:
Keywords: air quality; assessment; health; health equity; strategy; systematic review
Mesh:
Substances:
Year: 2016 PMID: 27918457 PMCID: PMC5201337 DOI: 10.3390/ijerph13121196
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Selection criteria for study inclusion and exclusion.
| Inclusion | Exclusion |
|---|---|
|
English language for the full article Scientific peer-reviewed articles, including conference articles Europe Union member countries Published between 1 January 1995 till 4 October 2015 Health outcome changes are associated with the concentration change of assessed air pollutants Papers with health assessment from air pollution, indicated by quantitative health indicators, such as mortality, life expectancy, hospital admissions, disease incidence or prevalence, or monetary health benefit, or self-reported health perception, or other indicators which can show the health status Papers focusing on ambient air pollution |
Non-English, even with English abstract Government report, project report, etc. Theoretical papers on policies or interventions and related health risks from air pollution Papers that only mentioned health in the conclusions or recommendations Papers assessing interventions that change air pollutant concentrations but not through reduction of emissions from pollution sources (such as green barriers, photocatalytic paints, ventilation, filtration system, etc.) Papers on indoor air pollution control interventions |
Figure 1Flow chart of the searching and screening procedure.
Summary of the included studies.
| Study & Publish Time | Country & Geographical Scale | Time Period Covered | Strategy or Intervention Description and Study Type (I,II,III) | Methods for Measuring Air Pollution Concentration and Health Outcome, and Brief Study Description | Assessed Air Pollutants a | Health Variables | If Co-Benefit b, Assessment Term, and Cofounders | Target Group |
|---|---|---|---|---|---|---|---|---|
| Aunan, K. et al. 1998 [ | Hungary | 1992–1993 to the following 5 years | The energy saving program, from National Energy Efficiency Improvement and Energy conservation Programs. |
Monitored | NO2, SO2, TSP d, Dust fallout, PM10, | Reduced air pollution attributed annual excess death for >65 and ≤65 years; Reduced air pollution attributed annual excess infant death (0–1 year); Reduced annual acute respiratory symptom days for children and adults; Reduced non-accidental and non-violent mortality; Reduced annual lung cancer cases; Monetary health benefit | Co-benefit | All population, stratified by age group |
|
Population/recipient data | ||||||||
| The study simulated the possible reduced damage to public health and other benefits obtained from reducing emissions of key air pollutants | ||||||||
| Clancy, L. et al. 2002 [ | Ireland | 1984–1990 | Ban of coal sales. |
Monitored | Black smoke, | Annual total non-trauma death; Respiratory death; Car-cerebrovascular death; Other non-trauma death(total minus cardiovascular and respiratory) | Short-term | All population, stratified by age group |
Population-standardised death rates | ||||||||
| The study compared the air pollution concentrations and health before and after the ban of coal sales in Dublin (1990) | ||||||||
| Burr, M.L. et al. 2004 [ | UK | Intermittent | By-pass construction in congested area. | Monitored | PM10, PM2.5 | Frequency of symptoms, including wheeze, winter cough, phlegm, consulted doctor, and rhinitis, and peak expiratory flow rate | Short-term | All population, in the experimental area |
Respiratory survey for health | ||||||||
| The study compared the air pollution concentrations and health outcomes (indicated by the prevalence of respiratory symptoms) between a congested street with a by-pass and uncongested street area | ||||||||
| Hutchinson, E.J. et al. 2004 [ | UK | 1993–1998 | Vehicle exhausts catalysts (VECs) | Simulated | PM10, NO2, O3 d, VOCs d, CO d | Monetary health value (all-cause mortality and respiratory hospital admission) | Short-term | All population |
| Calculated from mortality rate and hospital admission rate | ||||||||
| The study evaluated the environmental and health benefits of the emission reduction from VECs with available data for exposure assessment and projection for ex ante assessment (1998) | ||||||||
| Mindell, J. and Joffe, M. 2004 [ | UK | (1996–1998) 2004–2009 | UK National Air Quality Strategy Objectives for 2004 and 2009 | Monitored and targeted | PM10 | Delayed non-traumatic premature death; Emergency hospital admissions and consultations for respiratory diseases, including asthma, COPD, LRTI, and IHD e | Short and long-term | All population, stratified by age groups |
| Calculated from routine mortality and hospital admission data | ||||||||
| The study modelled the health impacts of PM10 reduction from the current levels (1996–1998) to the UK 2004 and 2009 target levels | ||||||||
| Tonne, C. et al. 2008 [ | UK | February 2003–February 2007 | Congestion Charging Scheme (CCS) | Simulated | NO2, PM10 | All-cause mortality, indicated by YLG | Co-benefit | All population, stratified by socioeconomic position |
| Calculated from mortality data | ||||||||
| The study modelled the air pollutant concentrations before and after the implementation of CCS, and then used exposure-response coefficients to predict the health gain indicated by years of life gained. | ||||||||
| Ballester, F. et al. 2008 [ | 26 EU cities | European Directive, European Parliament, U.S. Environmental Protection Agency and the World Health Organization on PM2.5 guideline (25 μg/m3, 20 μg/m3, 15 μg/m3, and 10 μg/m3, respectively) | Monitored & calculated | PM2.5 | Reduction in all-cause premature deaths; Total burden of all-cause mortality | Long-term | 30 years and older | |
| Calculated from the total mortality data | ||||||||
| The study estimated the mortality reduction if the PM2.5 concentration reduced to the targeted levels | ||||||||
| Perez, L. et al. 2009 [ | Spain | Post 2004 | Directive 2008/50/EC and WHO guidelines for PM10 (annual mean concentration of 20 μg/m3 and 40 μg/m3) | Targeted | PM10 | Monetary health value, indicated by VOLY f from all-cause mortality, morbidity (chronic bronchitis and asthma related symptoms), and hospital admissions of respiratory and cardiovascular causes | Short and long-term | All population, with infant death |
| Calculated | ||||||||
| The study estimated the avoided mortality and morbidity under the scenarios examined the annual mean PM10 concentration decreased to the WHO recommended level or to the European Union regulatory level | ||||||||
| Johansson, C. et al. 2009 [ | Sweden | 2003–2007 | Congestion tax system (Stockholm Trial) (Vehicles travelling into and out of the charge cordon were charged for every passage during weekdays) | Monitored and simulated | NOx, PM10 | Premature death, indicated by YLG f | Co-benefit | All population |
| Calculated from the mortality rate | ||||||||
| The study uses a test trial to measure and model the reduction of road use and then to model the reduction of traffic related PM10 and NOx; and using epidemiological mortality risk from NOx, calculates the avoidable premature death | ||||||||
| Woodcock, J. et al. 2009 [ | UK | 2010–2030 | Road transport interventions (Combination of active travel and lower-carbon emission motor vehicles) g
| Simulated | PM2.5 | Premature deaths from cardio-respiratory diseases and lung cancer in adults and acute respiratory infections for children DALYs f | Co-benefit | All population stratified by age groups |
| Simulated | ||||||||
| The study compared business as usual and with the interventions, and modelled the health benefit from reduction in PM2.5 concentration | ||||||||
| Boldo, E. et al. 2011 [ | Spain | 2004–2011 | Spain pollution control policies (Spain’s National Emissions Inventory, a baseline 2004 scenario and a projected 2011 scenario on a reduction of primary PM2.5, due to technological measures targeting the road transport sector, industry, agriculture, and power generation) | Targeted | PM2.5 | Avoided all-cause mortality | Long-term | 30–99 years group; |
| Calculated from the all-cause mortality and population data | ||||||||
| The study assessed the health benefit under the assumption that specific air quality policies were implemented successfully. | ||||||||
| Cesaroni, G. et al. 2011 [ | Italy | 2001–2005 | Limited traffic zone (LTZ) (Without policy scenario, optimistic scenario which assumed that all Euro 0 cars were replaced by Euro 4 cars, and pessimistic scenario which assumed that 10% of Euro 0 cars still running, and the rest 90% of Euro 0 were replaced by Euro 1–4 cars) | Simulated | NO2, PM10 | Total mortality, indicated by YLG | Long-term | People over 30 years old living along high-traffic road, stratified by the distance of 50 m, 50–100 m and 100–150 m, and stratified by SEP |
| Simulated | ||||||||
| The study calculated the pollution concentration according to the traffic data, and used a concentration-response function to assess the health benefit in two LTZs under the three scenarios | ||||||||
| Chanel, O. et al. 2014 [ | EU | Post 2000 | Three European Commission Directives to reduce the sulphur content in liquid fuels for vehicles (1994, 1996, 1999/2000) | Monitored & simulated | SO2 | Annual avoided respiratory, cardiovascular and total premature death (non- external); monetary health benefit indicated by VOLY | Short-term | All population, in 20 cities in EU |
| Calculated from the number of deaths | ||||||||
| The study compared the emission reduction and health gain before and after the intervention | ||||||||
| Cyrys, J. et al. 2014 [ | German | Post 2010 | Low emission zones (LEZs) since 2010 | Observed & targeted | Black smoke, PM10 | Annual avoided total death | Long-term | All population |
| Calculated | ||||||||
| The study analysed the scientific literatures on the effectiveness of LEZs to PM in German cities and then calculated the avoided death attributable to black smoke due to LEZs in Berlin | ||||||||
| Schucht, S. et al. 2015 [ | EU | 2005–2050 | EU air pollution legislation and climate policies | Simulated | PM2.5, O3 | Premature death from acute mortality of respiratory hospital admissions (65+ year) and minor restricted activity days (15–64 year); YLL f from chronic mortality of all ages; Monetary health benefit, indicated by cost of GDP h | Co-benefit | All population, stratified by age groups |
| Simulated | ||||||||
| The study compared the pollution change and health benefit under the scenario only with air pollution legislation and the scenario with both air pollution legislation and climate policies. |
a For assessed pollutants, we only included the pollutants that were used for health impact evaluation (excluding CO2). b Co-benefit was defined as the additional benefit of strategies which was above or beyond the direct aim of the strategies. c PJ, petajoule. d TSP, total suspended particles; O3, ozone; VOCs, volatile organic compounds; CO, carbon monoxide. e COPD, chronic obstructive pulmonary disease; LRTI, lower respiratory tract infection; IHD, ischaemic heart disease. f YLG, years of life gained; VOLY, value of a life year; DALYs, disability adjusted life years; YLL, years of life lost. g For strategy A, B and A+B, we only included the one with the highest air pollution concentration reduction and health impact. h GDP, gross domestic product.
Summary of health impact assessments and comments on health equity according to the type of the strategies.
| Strategy Type | Major Air Pollutants | Reference | Pollution Control Outcome or Targeted Level | Health Outcome * | Was Health Equity Assessed? If Not, Comment on Health Equity |
|---|---|---|---|---|---|
| PM2.5, PM10 | Mindell, J. and Joffe, M., 2004 [ | PM10 concentration with 35 permitted exceedances in 2004 and with 7 exceedances for 2009 for 24 h limit of 50 μg/m3; PM10 annual mean of 20 μg/m3 | Avoided 2–39 deaths per 100,000 if complying 2009 24 h PM10 target; 3.7–9.3 delayed death if complying UK 2009 annual PM10 target in Westminster | Yes, reducing air pollution would decrease inequities because exposure would be reduced most in deprived areas and because those who would benefit most were those with worse health, the very young and older people | |
| Ballester, F. et al., 2008 [ | Annual PM2.5 dropped to 25 μg/m3, 20 μg/m3, 15 μg/m3, and 10 μg/m3, respectively | Annual all-cause premature deaths avoided up to 114 (Cracow) per 100,000 if annual PM2.5 dropped to 10 μg/m3; Averagely 3% of the total mortality burden among 30 years and older can be reduced | No. | ||
| Perez, L. et al., 2009 [ | Annual mean ambient air PM10 concentration dropped from 50 μg/m3 to 20 μg/m3 (WHO) and to 40 μg/m3 (EU) | With WHO target, monetized health benefit was 6400 million Euros per year (1600 euro per capita) from mortality and morbidity | No. | ||
| Boldo, E. et al., 2011 [ | An average annual reduction of 0.7 μg/m3 in PM2.5 concentration | Annually, 6 per 100,000 population of all-cause deaths avoided for over 30-years group and 5 per 100,000 population avoided for the 25–74 years age group | No. | ||
| SO2, NOx, TSP, Black smoke | Aunan, K. et al., 1998 [ | SO2 concentration dropped by 5.7%, TSP dropped by 9.3%, NOx dropped by 10.1%, nmVOC (non-methane volatile organic compounds) dropped by 10%, and other greenhouse gases dropped | The program reduced air pollution attributed annual excess death by 9% for the whole population, reduced air pollution attributed annual excess infant death (0–1 year) by 11.4%, reduced annual acute respiratory symptom-days for children and adults by 11.2% and 9.8%, and reduced 25 annual lung cancer cases. The monetized health benefit was 1563 million US dollar | No. | |
| Clancy, L. et al., 2002 [ | Mean Black smoke concentration dropped by 70% and SO2 concentration dropped by 33.8% | Adjusted mortality rate decreased by 5.7% for total non-trauma, 10.3% for cardiovascular, 15.5% for respiratory, 7.9% for less than 60 years group, 6.2% for 60–74 years group and 4.5% for over than 75 years group | No. | ||
| Chanel, O. et al., 2014 [ | Gradual decline in SO2 concentration | Postponed annual 2212 premature deaths for 20 cities after 2000 comparing with pre 1993; Annual monetized health benefit from mortality was 191.6 million Euro | No. | ||
| NOx, PM | Burr, M.L. et al., 2003 [ | PM10 concentration decreased by 23% (8.0 μg /m3) in the congested streets and by 29% (3.4 μg /m3) in the uncongested; PM2.5 decreased by 23.5% in congested streets and 26.6% in uncongested streets | Clear improvement around the congested streets for rhinitis symptoms, but no clear differences for low respiratory symptoms | No. | |
| Hutchinson, E.J. et al., 2004 [ | NO2 concentration dropped by around 20%, PM10 dropped by around 10%, O3 increased slightly, VOCs dropped by around 30%, and CO dropped by more than 70% | Net health benefit of 510 million Pound to 1998, and 2157 million Pound to 2005 with the combined concentration change of NO2, PM10 and O3 | No. | ||
| Tonne, C. et al., 2008 [ | NO2 and PM10 concentrations dropped moderately | Total 183 YLG per 100,000 for NO2 reduction and 63 YLG for PM10 reduction per 10 years in CCS area | Yes, more deprived areas had higher air pollution concentration, and these areas also experienced greater air pollution reductions and mortality benefits compared to less deprived areas | ||
| Johansson, C. et al., 2009 [ | NOx emission dropped by up to 12%, and PM10 dropped by up to 7% | Annually 20.6 YLG per 100,000 people for NOx reduction | No. | ||
| Cesaroni, G. et al., 2011 [ | NO2 and PM10 concentrations decreased by up to 23% and 10% by the policy | 921 YLG per 100,000 along busy road for NO2 reduction, average 686 YLG per 100,000 from NO2, and 116 YLG per 100,000 for PM10 within 150 m of the High traffic Road with the intervention during 15 years | Yes, because wealthy people lived in city center in Rome. High socio-economic population gained most of the health benefit, thus it increased the SEP inequity | ||
| Cyrys, J. et al., 2014 [ | PM10 concentration dropped by up to 10%, and diesel particle dropped by 58% | Annually 144 avoided death per million due to diesel particle decrease | No. | ||
| PM2.5, O3 | Woodcock, J. et al., 2009 [ | PM2.5 concentration decreased by up to 9.7% | PM2.5 concentration reduction avoided 33 related premature deaths and 319 DALYs per million population | No. | |
| Schucht, S. et al., 2015 [ | For population weighted annual average PM2.5 concentration, with mere air quality policies, 75% decrease from 2005 to 2050, with extra 68% reduction if combining climate policies; For SOMO35 (ozone concentrations accumulated dose over a threshold of 35 ppb), 1% increase without climate policies, and 86% decrease with climate policies | Adjusted by the EU population change, for chronic PM2.5 mortality, air quality control policies would reduce YLL attributable to PM2.5 from 4.6 million to 1 million from 2005 to 2050, with further 300,000 reduction if combining with climate policy. For ozone, premature deaths from acute exposure to ozone would increase from 31,000 to 48,000 from 2005 to 2050, while they would decrease to 7000 with climate mitigation policies at a global level. The monetized health damage would reduce from 3% of the EU GDP in 2005 to 0.4% in 2050 merely with air quality control policies, and to 0.1% if combining with climate policies. | No. |
* Several studies modelled the health outcomes under different scenarios, but here we only include the one with the largest health benefit.